ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

China's Sinovac to crank up vaccine output for foreign demand

Pharma company is integral to Beijing's medical diplomacy

Sinovac built its new Beijing vaccine production site in just four months.   © Reuters

BEIJING -- China's Sinovac Biotech is prepared to rapidly increase output of its coronavirus vaccine candidate in response to demand overseas, the head of the pharmaceutical maker said Thursday,

Sinovac just completed a plant in Beijing in July capable of producing 300 million doses of a vaccine yearly. Construction took roughly four months. The company opened the plant to foreign media for the first time Thursday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more